Hydrogen sulfide as a potent cardiovascular protective agent

Clinica Chimica Acta

Volumn 437, Issue , 2014, Pages 78-87

  Yu, Xiao Hua ^a   Cui, Li Bao ^b   Wu, Kai ^c   Zheng, Xi Long ^d   Cayabyab, Francisco S ^e   Chen, Zhi Wei ^c   Tang, Chao Ke ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b Central Hospital of Hengyang City   (China)

^c THE FIRST AFFILIATED HOSPITAL OF UNIVERSITY OF SOUTH CHINA   (China)

^d UNIVERSITY OF CALGARY   (Canada)

^e UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Atherosclerosis; CHD; CSE; Heart failure

Indexed keywords

3 MERCAPTOPYRUVATE SULFURTRANSFERASE; AMINOTRANSFERASE; ARGININE; CARBON MONOXIDE; CARDIOVASCULAR AGENT; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; CYSTEINE AMINOTRANSFERASE; DIALLYL TRISULFIDE; DICLOFENAC; HYDROGEN SULFIDE; NITRIC OXIDE; ONION EXTRACT; SG 1002; SODIUM THIOSULFATE; SULFUR DIOXIDE; SULFURTRANSFERASE; UNCLASSIFIED DRUG; CARDIOTONIC AGENT;

ANGIOGENESIS; APOPTOSIS; ATHEROSCLEROSIS; CONCENTRATION (PARAMETERS); DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG STRUCTURE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE INJURY; HEART PROTECTION; HUMAN; HYPERTENSION; INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; STRUCTURE ANALYSIS; TOXICITY TESTING; VASODILATATION; ANIMAL; CARDIOVASCULAR DISEASES; CHEMISTRY; METABOLISM;

ANIMALS; CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; HUMANS; HYDROGEN SULFIDE;

EID: 84905279994     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.07.012     Document Type: Review

References (119)

1. Yu Y.P., Chi X.L., Liu L.J. A hypothesis: hydrogen sulfide might be neuroprotective against subarachnoid hemorrhage induced brain injury. Scientific World Journal 2014, 2014:432318.
2. Kolluru G.K., Shen X., Bir S.C., et al. Hydrogen sulfide chemical biology: pathophysiological roles and detection. Nitric Oxide 2013, 35:5-20.
3. Polhemus D.J., Lefer D.J. Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease. Circ Res 2014, 114:730-737.
4. Guo W., Cheng Z.Y., Zhu Y.Z. Hydrogen sulfide and translational medicine. Acta Pharmacol Sin 2013, 34:1284-1291.
5. Lavu M., Bhushan S., Lefer D.J. Hydrogen sulfide-mediated cardioprotection: mechanisms and therapeutic potential. Clin Sci (Lond) 2011, 120:219-229.
6. Shibuya N., Tanaka M., Yoshida M., et al. 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal 2009, 11:703-714.
7. Shibuya N., Mikami Y., Kimura Y., et al. Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J Biochem 2009, 146:623-626.
8. 2S by cystathionine beta-synthase via the condensation of cysteine and homocysteine. J Biol Chem 2004, 279:52082-52086.
9. Olas B. Hydrogen sulfide in hemostasis: friend or foe?. Chem Biol Interact 2014, 217:49-56.
10. Kimura H. Hydrogen sulfide: its production, release and functions. Amino Acids 2011, 41:113-121.
11. Kimura H. Metabolic turnover of hydrogen sulfide. Front Physiol 2012, 3:101.
12. Kimura H. Physiological role of hydrogen sulfide and polysulfide in the central nervous system. Neurochem Int 2013, 63:492-497.
13. Stein A., Bailey S.M. Redox biology of hydrogen sulfide: implications for physiology, pathophysiology, and pharmacology. Redox Biol 2013, 1:32-39.
14. Olson K.R., DeLeon E.R., Liu F. Controversies and conundrums in hydrogen sulfide biology. Nitric oxide 2014, [Epub ahead of print].
15. Wu X.C., Zhang W.J., Wu D.Q., et al. Using carbon nanotubes to absorb low-concentration hydrogen sulfide in fluid. IEEE Trans Nanobioscience 2006, 5:204-209.
16. Lippert A.R., New E.J., Chang C.J. Reaction-based fluorescent probes for selective imaging of hydrogen sulfide in living cells. J Am Chem Soc 2011, 133:10078-10080.
17. Dongo E., Hornyak I., Benko Z., et al. The cardioprotective potential of hydrogen sulfide in myocardial ischemia/reperfusion injury (review). Acta Physiol Hung 2011, 98:369-381.
18. Kashfi K., Olson K.R. Biology and therapeutic potential of hydrogen sulfide and hydrogen sulfide-releasing chimeras. Biochem Pharmacol 2013, 85:689-703.
19. Wagner F., Asfar P., Calzia E., et al. Bench-to-bedside review: hydrogen sulfide-the third gaseous transmitter: applications for critical care. Crit Care 2009, 13:213.
20. Baragatti B., Ciofini E., Sodini D., et al. Hydrogen sulfide in the mouse ductus arteriosus: a naturally occurring relaxant with potential EDHF function. Am J Physiol Heart Circ Physiol 2013, 304:H927-H934.
21. 2S generation by CBS, CSE, and 3MST gene therapy improves ex vivo renovascular relaxation in hyperhomocysteinemia. Am J Physiol Cell Physiol 2012, 303:C41-C51.
22. 2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 2008, 322:587-590.
23. 2S contributes to the hepatic arterial buffer response and mediates vasorelaxation of the hepatic artery via activation of K(ATP) channels. Am J Physiol Gastrointest Liver Physiol 2008, 295:G1266-G1273.
24. Jiang B., Tang G., Cao K., et al. Molecular mechanism for H(2)S-induced activation of K(ATP) channels. Antioxid Redox Signal 2010, 12:1167-1178.
25. Jackson-Weaver O., Osmond J.M., Riddle M.A., et al. Hydrogen sulfide dilates rat mesenteric arteries by activating endothelial large-conductance Ca(2)(+)-activated K(+) channels and smooth muscle Ca(2)(+) sparks. Am J Physiol Heart Circ Physiol 2013, 304:H1446-H1454.
26. Martelli A., Testai L., Breschi M.C., et al. Vasorelaxation by hydrogen sulphide involves activation of Kv7 potassium channels. Pharmacol Res 2013, 70:27-34.
27. Lim J.J., Liu Y.H., Khin E.S., et al. Vasoconstrictive effect of hydrogen sulfide involves downregulation of cAMP in vascular smooth muscle cells. Am J Physiol Cell Physiol 2008, 295:C1261-C1270.
28. Webb G.D., Lim L.H., Oh V.M., et al. Contractile and vasorelaxant effects of hydrogen sulfide and its biosynthesis in the human internal mammary artery. J Pharmacol Exp Ther 2008, 324:876-882.
29. Kubo S., Kajiwara M., Kawabata A. Dual modulation of the tension of isolated gastric artery and gastric mucosal circulation by hydrogen sulfide in rats. Inflammopharmacology 2007, 15:288-292.
30. Cai W.J., Wang M.J., Moore P.K., et al. The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc Res 2007, 76:29-40.
31. Szabo C., Coletta C., Chao C., et al. Tumor-derived hydrogen sulfide, produced by cystathionine-beta-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer. Proc Natl Acad Sci U S A 2013, 110:12474-12479.
32. Papapetropoulos A., Pyriochou A., Altaany Z., et al. Hydrogen sulfide is an endogenous stimulator of angiogenesis. Proc Natl Acad Sci U S A 2009, 106:21972-21977.
33. Bae M., Jang S., Lim J.W., et al. Protective effect of Korean Red Ginseng extract against Helicobacter pylori-induced gastric inflammation in Mongolian gerbils. J Ginseng Res 2014, 38:8-15.
34. Yun T.K., Zheng S., Choi S.Y., et al. Non-organ-specific preventive effect of long-term administration of Korean red ginseng extract on incidence of human cancers. J Med Food 2010, 13:489-494.
35. Choi K.S., Song H., Kim E.H., et al. Inhibition of hydrogen sulfide-induced angiogenesis and inflammation in vascular endothelial cells: potential mechanisms of gastric cancer prevention by Korean Red ginseng. J Ginseng Res 2012, 36:135-145.
36. Kohn C., Dubrovska G., Huang Y., et al. Hydrogen sulfide: potent regulator of vascular tone and stimulator of angiogenesis. Int J Biomed Sci 2012, 8:81-86.
37. Liu X., Pan L., Zhuo Y., et al. Hypoxia-inducible factor-1alpha is involved in the pro-angiogenic effect of hydrogen sulfide under hypoxic stress. Biol Pharm Bull 2010, 33:1550-1554.
38. Wang M.J., Cai W.J., Li N., et al. The hydrogen sulfide donor NaHS promotes angiogenesis in a rat model of hind limb ischemia. Antioxid Redox Signal 2010, 12:1065-1077.
39. Ang A.D., Rivers-Auty J., Hegde A., et al. The effect of CSE gene deletion in caerulein-induced acute pancreatitis in the mouse. Am J Physiol Gastrointest Liver Physiol 2013, 305:G712-G721.
40. Dal-Secco D., Cunha T.M., Freitas A., et al. Hydrogen sulfide augments neutrophil migration through enhancement of adhesion molecule expression and prevention of CXCR2 internalization: role of ATP-sensitive potassium channels. J Immunol 2008, 181:4287-4298.
41. Zhi L., Ang A.D., Zhang H., et al. Hydrogen sulfide induces the synthesis of proinflammatory cytokines in human monocyte cell line U937 via the ERK-NF-kappaB pathway. J Leukoc Biol 2007, 81:1322-1332.
42. Whiteman M., Li L., Rose P., et al. The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages. Antioxid Redox Signal 2010, 12:1147-1154.
43. Guo R., Wu K., Chen J., et al. Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NFkappaB pathway in H9c2 cardiac cells. Cell Physiol Biochem 2013, 32:1668-1680.
44. Manna P., Jain S.K. l-Cysteine and hydrogen sulfide increase PIP3 and AMPK/PPARgamma expression and decrease ROS and vascular inflammation markers in high glucose treated human U937 monocytes. J Cell Biochem 2013, 114:2334-2345.
45. 2S against chemical hypoxia-induced inflammation in PC12 cells. Neurochem Res 2013, 38:1454-1466.
46. 2S and its role in redox signaling. Biochim Biophys Acta 2014, 1844:1355-1366.
47. Tang X.Q., Yang C.T., Chen J., et al. Effect of hydrogen sulphide on beta-amyloid-induced damage in PC12 cells. Clin Exp Pharmacol Physiol 2008, 35:180-186.
48. Al-Magableh M.R., Kemp-Harper B.K., Ng H.H., et al. Hydrogen sulfide protects endothelial nitric oxide function under conditions of acute oxidative stress in vitro. Naunyn Schmiedebergs Arch Pharmacol 2014, 387:67-74.
49. Yan S.K., Chang T., Wang H., et al. Effects of hydrogen sulfide on homocysteine-induced oxidative stress in vascular smooth muscle cells. Biochem Biophys Res Commun 2006, 351:485-491.
50. Koike S., Ogasawara Y., Shibuya N., et al. Polysulfide exerts a protective effect against cytotoxicity caused by t-buthylhydroperoxide through Nrf2 signaling in neuroblastoma cells. FEBS Lett 2013, 587:3548-3555.
51. Zhu X., Tang Z., Cong B., et al. Estrogens increase cystathionine-gamma-lyase expression and decrease inflammation and oxidative stress in the myocardium of ovariectomized rats. Menopause 2013, 20:1084-1091.
52. Qi H.N., Cui J., Liu L., et al. Exogenous hydrogen sulfide delays the senescence of human umbilical vein endothelial cells by lessening oxidative stress. Sheng Li Xue Bao 2012, 64:425-432.
53. Fan H.N., Wang H.J., Yang-Dan C.R., et al. Protective effects of hydrogen sulfide on oxidative stress and fibrosis in hepatic stellate cells. Mol Med Rep 2013, 7:247-253.
54. Baskar R., Sparatore A., Del Soldato P., et al. Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation. Eur J Pharmacol 2008, 594:1-8.
55. 2S-induced pancreatic acinar cell apoptosis is mediated via JNK and p38 MAP kinase. J Cell Mol Med 2008, 12:1374-1383.
56. Zhou X., Lu X. Hydrogen sulfide inhibits high-glucose-induced apoptosis in neonatal rat cardiomyocytes. Exp Biol Med (Maywood) 2013, 238:370-374.
57. Luo Y., Yang X., Zhao S., et al. Hydrogen sulfide prevents OGD/R-induced apoptosis via improving mitochondrial dysfunction and suppressing an ROS-mediated caspase-3 pathway in cortical neurons. Neurochem Int 2013, 63:826-831.
58. Pan H., Chen D., Liu B., et al. Effects of sodium hydrosulfide on intestinal mucosal injury in a rat model of cardiac arrest and cardiopulmonary resuscitation. Life Sci 2013, 93:24-29.
59. Guo R., Lin J., Xu W., et al. Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells. Int J Mol Med 2013, 31:644-650.
60. Yu X.H., Qian K., Jiang N., et al. ABCG5/ABCG8 in cholesterol excretion and atherosclerosis. Clin Chim Acta 2014, 428:82-88.
61. Mani S., Untereiner A., Wu L., et al. Hydrogen sulfide and the pathogenesis of atherosclerosis. Antioxid Redox Signal 2014, 20:805-817.
62. Mani S., Li H., Untereiner A., et al. Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis. Circulation 2013, 127:2523-2534.
63. 2S and adrenomedulin in rat atherosclerosis. Curr Pharm Biotechnol 2011, 12:1427-1439.
64. Chen S.J., Yan X.H., Zhu X.Y., et al. Effect of hydrogen sulfide on antiatherosclerosis in rats. Zhongguo Ying Yong Sheng Li Xue Za Zhi 2010, 26:1-7.
65. Ma B., Liang G., Zhang F., et al. Effect of hydrogen sulfide on restenosis of peripheral arteries after angioplasty. Mol Med Rep 2012, 5:1497-1502.
66. Yu X.H., Fu Y.C., Zhang D.W., et al. Foam cells in atherosclerosis. Clin Chim Acta 2013, 424:245-252.
67. Zhao Z.Z., Wang Z., Li G.H., et al. Hydrogen sulfide inhibits macrophage-derived foam cell formation. Exp Biol Med (Maywood) 2011, 236:169-176.
68. Liu Z., Han Y., Li L., et al. The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(-/-) mice. Br J Pharmacol 2013, 169:1795-1809.
69. Li G.S., He P.P., Wang B., et al. The study of hydrogen sulfide up-regulates the expression of ABCA1 and promotes the cholesterol efflux in foam cells. Chongqing Med 2013, 42:3596-3598.
70. Wang X.H., Wang F., You S.J., et al. Dysregulation of cystathionine gamma-lyase (CSE)/hydrogen sulfide pathway contributes to ox-LDL-induced inflammation in macrophage. Cell Signal 2013, 25:2255-2262.
71. Wang Y., Zhao X., Jin H., et al. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2009, 29:173-179.
72. Klocke R., Tian W., Kuhlmann M.T., et al. Surgical animal models of heart failure related to coronary heart disease. Cardiovasc Res 2007, 74:29-38.
73. 2S in patients with coronary heart disease. Di Yi Jun Yi Da Xue Xue Bao 2005, 25:951-954.
74. Zunnunov Z.R. Efficacy and safety of hydrogen sulfide balneotherapy in ischemic heart disease the arid zone. Ter Arkh 2004, 76:15-18.
75. Ilkan Z., Mustafa F., Apostoli G., et al. OP16 Hydrogen sulfide inhibits human platelet aggregation. Nitric Oxide 2013, 31(Suppl. 2):S26.
76. Xie X., Sun A., Zhu W., et al. Transplantation of mesenchymal stem cells preconditioned with hydrogen sulfide enhances repair of myocardial infarction in rats. Tohoku J Exp Med 2012, 226:29-36.
77. Qipshidze N., Metreveli N., Mishra P.K., et al. Hydrogen sulfide mitigates cardiac remodeling during myocardial infarction via improvement of angiogenesis. Int J Biol Sci 2012, 8:430-441.
78. 2S generation. Pharmacology 2008, 82:201-213.
79. Kondo K., Bhushan S., King A.L., et al. H(2)S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase. Circulation 2013, 127:1116-1127.
80. Polhemus D.J., Kondo K., Bhushan S., et al. Hydrogen sulfide attenuates cardiac dysfunction after heart failure via induction of angiogenesis. Circ Heart Fail 2013, 6:1077-1086.
81. Wang X., Wang Q., Guo W., et al. Hydrogen sulfide attenuates cardiac dysfunction in a rat model of heart failure: a mechanism through cardiac mitochondrial protection. Biosci Rep 2011, 31:87-98.
82. Liu Y.H., Lu M., Xie Z.Z., et al. Hydrogen sulfide prevents heart failure development via inhibition of renin release from mast cells in isoproterenol-treated rats. Antioxid Redox Signal 2014, 20:759-769.
83. Nishida M., Toyama T., Akaike T. Role of 8-nitro-cGMP and its redox regulation in cardiovascular electrophilic signaling. J Mol Cell Cardiol 2014, 73C:10-17.
84. Nishida M., Sawa T., Kitajima N., et al. Hydrogen sulfide anion regulates redox signaling via electrophile sulfhydration. Nat Chem Biol 2012, 8:714-724.
85. Huang J., Wang D., Zheng J., et al. Hydrogen sulfide attenuates cardiac hypertrophy and fibrosis induced by abdominal aortic coarctation in rats. Mol Med Rep 2012, 5:923-928.
86. Nicholson C.K., Lambert J.P., Molkentin J.D., et al. Thioredoxin 1 is essential for sodium sulfide-mediated cardioprotection in the setting of heart failure. Arterioscler Thromb Vasc Biol 2013, 33:744-751.
87. Pan L.L., Liu X.H., Shen Y.Q., et al. Inhibition of NADPH oxidase 4-related signaling by sodium hydrosulfide attenuates myocardial fibrotic response. Int J Cardiol 2013, 168:3770-3778.
88. Wang K., Ahmad S., Cai M., et al. Dysregulation of hydrogen sulfide producing enzyme cystathionine gamma-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia. Circulation 2013, 127:2514-2522.
89. Pan X., Zhang Y., Tao S. Effects of Tai Chi exercise on blood pressure and plasma levels of nitric oxide, carbon monoxide and hydrogen sulfide in real-world patients with essential hypertension. Clin Exp Hypertens 2014, [Epub ahead of print].
90. 2S) reduces blood pressure and prevents the progression of diabetic nephropathy in spontaneously hypertensive rats. Ren Fail 2012, 34:203-210.
91. Zhong G., Chen F., Cheng Y., et al. The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase. J Hypertens 2003, 21:1879-1885.
92. Zhang J., Chen S., Liu H., et al. Hydrogen sulfide prevents hydrogen peroxide-induced activation of epithelial sodium channel through a PTEN/PI(3,4,5)P3 dependent pathway. PLoS One 2013, 8:e64304.
93. Lu M., Liu Y.H., Goh H.S., et al. Hydrogen sulfide inhibits plasma renin activity. J Am Soc Nephrol 2010, 21:993-1002.
94. Laggner H., Hermann M., Esterbauer H., et al. The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells. J Hypertens 2007, 25:2100-2104.
95. Xiaohui L., Junbao D., Lin S., et al. Down-regulation of endogenous hydrogen sulfide pathway in pulmonary hypertension and pulmonary vascular structural remodeling induced by high pulmonary blood flow in rats. Circ J 2005, 69:1418-1424.
96. Yanfei W., Lin S., Junbao D., et al. Impact of L-arginine on hydrogen sulfide/cystathionine-gamma-lyase pathway in rats with high blood flow-induced pulmonary hypertension. Biochem Biophys Res Commun 2006, 345:851-857.
97. Ariyaratnam P., Loubani M., Morice A.H. Hydrogen sulphide vasodilates human pulmonary arteries: a possible role in pulmonary hypertension?. Microvasc Res 2013, 90:135-137.
98. Li X., Du J., Jin H., et al. Sodium hydrosulfide alleviates pulmonary artery collagen remodeling in rats with high pulmonary blood flow. Heart Vessels 2008, 23:409-419.
99. Wei H.L., Zhang C.Y., Jin H.F., et al. Hydrogen sulfide regulates lung tissue-oxidized glutathione and total antioxidant capacity in hypoxic pulmonary hypertensive rats. Acta Pharmacol Sin 2008, 29:670-679.
100. Luo L., Liu D., Tang C., et al. Sulfur dioxide upregulates the inhibited endogenous hydrogen sulfide pathway in rats with pulmonary hypertension induced by high pulmonary blood flow. Biochem Biophys Res Commun 2013, 433:519-525.
101. 2S inhibition of chemical hypoxia-induced proliferation of HPASMCs is mediated by the upregulation of COX-2/PGI2. Int J Mol Med 2014, 33:359-366.
102. Li W., Jin H.F., Liu D., et al. Hydrogen sulfide induces apoptosis of pulmonary artery smooth muscle cell in rats with pulmonary hypertension induced by high pulmonary blood flow. Chin Med J (Engl) 2009, 122:3032-3038.
103. Jin H., Wang Y., Wang X., et al. Sulfur dioxide preconditioning increases antioxidative capacity in rat with myocardial ischemia reperfusion (I/R) injury. Nitric Oxide 2013, 32:56-61.
104. Luan H.F., Zhao Z.B., Zhao Q.H., et al. Hydrogen sulfide postconditioning protects isolated rat hearts against ischemia and reperfusion injury mediated by the JAK2/STAT3 survival pathway. Braz J Med Biol Res 2012, 45:898-905.
105. Peake B.F., Nicholson C.K., Lambert J.P., et al. Hydrogen sulfide preconditions the db/db diabetic mouse heart against ischemia-reperfusion injury by activating Nrf2 signaling in an Erk-dependent manner. Am J Physiol Heart Circ Physiol 2013, 304:H1215-H1224.
106. Osipov R.M., Robich M.P., Feng J., et al. Effect of hydrogen sulfide in a porcine model of myocardial ischemia-reperfusion: comparison of different administration regimens and characterization of the cellular mechanisms of protection. J Cardiovasc Pharmacol 2009, 54:287-297.
107. Shymans'ka T.V., Hoshovs'ka Iu V., Semenikhina O.M., et al. Effect of hydrogen sulfide on isolated rat heart reaction under volume load and ischemia-reperfusion. Fiziol Zh 2012, 58:57-66.
108. Zhang Z., Huang H., Liu P., et al. Hydrogen sulfide contributes to cardioprotection during ischemia-reperfusion injury by opening K ATP channels. Can J Physiol Pharmacol 2007, 85:1248-1253.
109. 2S-releasing drugs as pharmaceuticals. J Med Chem 2010, 53:6275-6286.
110. Li L., Whiteman M., Guan Y.Y., et al. Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide. Circulation 2008, 117:2351-2360.
111. Grambow E., Mueller-Graf F., Delyagina E., et al. Effect of the hydrogen sulfide donor GYY4137 on platelet activation and microvascular thrombus formation in mice. Platelets 2014, 25:166-174.
112. Pircher J., Fochler F., Czermak T., et al. Hydrogen sulfide-releasing aspirin derivative ACS14 exerts strong antithrombotic effects in vitro and in vivo. Arterioscler Thromb Vasc Biol 2012, 32:2884-2891.
113. 2S in periadventitial vasoregulation of rat and mouse aortas. PLoS One 2012, 7:e41951.
114. Benavides G.A., Squadrito G.L., Mills R.W., et al. Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci U S A 2007, 104:17977-17982.
115. Predmore B.L., Kondo K., Bhushan S., et al. The polysulfide diallyl trisulfide protects the ischemic myocardium by preservation of endogenous hydrogen sulfide and increasing nitric oxide bioavailability. Am J Physiol Heart Circ Physiol 2012, 302:H2410-H2418.
116. Chuah S.C., Moore P.K., Zhu Y.Z. S-allylcysteine mediates cardioprotection in an acute myocardial infarction rat model via a hydrogen sulfide-mediated pathway. Am J Physiol Heart Circ Physiol 2007, 293:H2693-H2701.
117. Wang Q., Liu H.R., Mu Q., et al. S-propargyl-cysteine protects both adult rat hearts and neonatal cardiomyocytes from ischemia/hypoxia injury: the contribution of the hydrogen sulfide-mediated pathway. J Cardiovasc Pharmacol 2009, 54:139-146.
118. Estruch R., Ros E., Salas-Salvado J., et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013, 368:1279-1290.
119. Martinez-Gonzalez M.A., Bes-Rastrollo M. Dietary patterns, Mediterranean diet, and cardiovascular disease. Curr Opin Lipidol 2014, 25:20-26.